Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_assertion type Assertion NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_head.
- NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_assertion description "[Targeting the mineralocorticoid receptor (MR) offers one approach for the treatment of heart failure with current strategies for novel MR therapeutics focusing on harnessing their cardio-protective benefits, but limiting the side effects of existing agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_provenance.
- NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_assertion evidence source_evidence_literature NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_provenance.
- NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_assertion SIO_000772 25335936 NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_provenance.
- NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_assertion wasDerivedFrom befree-2016 NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_provenance.
- NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_assertion wasGeneratedBy ECO_0000203 NP1231326.RAQ5jfBGnnDC1cpfeChbmGD0a0PKXQhl29XfoxhA5nmZg130_provenance.